A new Canadian study discovers that psychedelic drugs may help curb domestic violence committed by men with substance abuse problems.
In the observational study, researchers followed inmates with histories of substance abuse after they were released from prisons.
Investigators found that 42 percent of U.S. adult male inmates who did not take psychedelic drugs were arrested within six years for domestic battery after their release. However, only 27 percent of inmates who had taken drugs such as LSD, psilocybin (commonly known as magic mushrooms) and MDMA (ecstasy) were charged with battery.
In the study, researchers followed 302 inmates for an average of six years after they were released. All those observed had histories of substance use disorders.
“While not a clinical trial, this study, in stark contrast to prevailing attitudes that views these drugs as harmful, speaks to the public health potential of psychedelic medicine,” said Dr. Zach Walsh, the co-director for University of British Columbia Okanagan’s Centre for the Advancement of Psychological Science and Law.
“As existing treatments for intimate partner violence are insufficient, we need to take new perspectives such as this seriously.”
“Intimate partner violence is a major public health problem and existing treatments to reduce reoffending are insufficient,” he says. “With proper dosage, set, and setting we might see even more profound effects. This definitely warrants further research.”
The study, published in the Journal of Psychopharmacology, was co-authored by University of Alabama’s Dr. Peter Hendricks. Hendricks predicts that psilocybin and related compounds could revolutionize the mental health field.
“Although we’re attempting to better understand how or why these substances may be beneficial, one explanation is that they can transform people’s lives by providing profoundly meaningful spiritual experiences that highlight what matters most,” Hendricks said.
“Often, people are struck by the realization that behaving with compassion and kindness toward others is high on the list of what matters.”
While research on the benefits of psychedelic drugs took place in the 1950 to the 1970s, primarily to treat mental illness, it was stopped due to the reclassification of the drugs to a controlled substance in the mid-1970s. Recent years have seen a resurgence of interest in psychedelic medicine.
“The experiences of unity, positivity, and transcendence that characterize the psychedelic experience may be particularly beneficial to groups that are frequently marginalized and isolated, such as the incarcerated men who participated in this study,” said Walsh.